CureVac N.V. (CVAC)

CureVac Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,049	765	943	1,147	6,418	14,306
Market Cap Growth	58.58%	-18.86%	-17.82%	-82.13%	-55.14%	-
Enterprise Value	602	590	496	657	5,253	13,292
Last Close Price	4.66	3.41	4.21	6.03	34.31	81.07
PE Ratio	4.98	4.56	-	-	-	-
PS Ratio	9.02	1.38	15.87	15.92	54.79	239.30
PB Ratio	0.82	1.06	1.65	2.01	8.20	16.44
P/TBV Ratio	1.06	1.10	1.75	2.14	8.35	16.76
P/FCF Ratio	-	8.44	-	-	-	24.06
P/OCF Ratio	-	7.25	-	-	-	22.39
EV/Sales Ratio	7.26	1.06	8.35	9.12	44.85	222.35
EV/EBITDA Ratio	2.65	2.56	-	-	-	-
EV/EBIT Ratio	2.82	2.72	-	-	-	-
EV/FCF Ratio	-	6.51	-	-	-	22.36
Debt / Equity Ratio	0.04	0.06	0.08	0.08	0.04	0.08
Debt / EBITDA Ratio	0.18	0.17	-	-	-	-
Debt / FCF Ratio	-	0.45	-	-	-	0.11
Asset Turnover	-	0.67	0.07	0.07	0.08	0.06
Inventory Turnover	-	8.34	4.76	3.97	6.09	1.37
Quick Ratio	1.88	7.11	2.37	3.44	2.43	5.39
Current Ratio	3.70	7.28	2.57	3.74	2.63	5.61
Return on Equity (ROE)	-	26.73%	-49.55%	-40.77%	-58.82%	-38.63%
Return on Assets (ROA)	-	16.48%	-20.18%	-13.90%	-48.24%	-10.17%
Return on Capital (ROIC)	-	20.26%	-29.33%	-21.71%	-86.79%	-20.79%
Return on Capital Employed (ROCE)	20.20%	28.70%	-44.20%	-31.90%	-128.70%	-10.60%
Earnings Yield	14.40%	21.95%	-30.50%	-23.20%	-7.30%	-1.10%
FCF Yield	-13.83%	11.85%	-37.54%	-34.86%	-15.19%	4.16%
Buyback Yield / Dilution	38.70%	-1.57%	-16.84%	-1.65%	-40.71%	-36.72%

Updated Nov 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q